lutetium has been researched along with Ache in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 3 (30.00) | 2.80 |
Authors | Studies |
---|---|
Flux, G; Liepe, K; Murray, I | 1 |
Allen, JC; Kanesvaran, R; Lam, WWC; Ler, ASL; Ng, DCE; Somanesan, S; Tay, YS; Thang, SP; Tong, AKT; Wong, ASC | 1 |
Bakar, HE; Begec, T; Cayırlı, YB; Celen, YZ; Elboga, U; Eryilmaz, K; Kilbas, B; Mercanoglu, G; Sahin, E | 1 |
Bins, A; Braat, A; de Keizer, B; Hunting, J; Krijger, G; Lam, M; Mehra, N; van Kalmthout, L; van Leeuwaarde, R; Ververs, T | 1 |
Baum, RP; Meckel, M; Nauth, A; Puranik, AD; Rösch, F; Timpe, J; Zhernosekov, K | 1 |
Baum, RP; Klette, I; Kulkarni, HR; Mueller, D; Schottelius, M; Schuchardt, C; Singh, A; Wester, HJ; Wiessalla, S; Wirtz, M | 1 |
Abbasi, IA | 1 |
Banerjee, S; Chakraborty, S; Das, T; Pillai, MR; Samuel, G; Sarma, HD; Unni, PR; Venkatesh, M | 1 |
Banerjee, S; Chakraborty, S; Das, T; Sarma, HD; Venkatesh, M | 1 |
Ando, A; Ando, I; Fujita, N; Kataiwa, A; Kazuma, K; Kinuya, S; Nakagawa, M; Tonami, N | 1 |
1 review(s) available for lutetium and Ache
Article | Year |
---|---|
Dosimetry of Bone Seeking Beta Emitters for Bone Pain Palliation Metastases.
Topics: Bone and Bones; Bone Neoplasms; Humans; Lutetium; Pain; Radiopharmaceuticals; Rhenium; Tissue Distribution; Zoledronic Acid | 2022 |
1 trial(s) available for lutetium and Ache
Article | Year |
---|---|
Clinical outcomes of 177lutetium-prostate-specific membrane antigen therapy in advanced prostate cancer-a prospective pilot study in an Asian population.
Topics: Adult; Aged; Asian People; Humans; Kallikreins; Lutetium; Male; Middle Aged; Pain; Pilot Projects; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Survival Analysis; Treatment Outcome | 2020 |
8 other study(ies) available for lutetium and Ache
Article | Year |
---|---|
An automated synthesis of 177Lu-EDTMP as an efficient bone-seeking therapeutic radiopharmaceutical.
Topics: Aged; Automation; Bone Neoplasms; Female; Humans; Injections, Intravenous; Lutetium; Male; Molecular Structure; Organometallic Compounds; Pain; Pain Management; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals | 2021 |
First Experience With 177Lu-PSMA-617 Therapy for Advanced Prostate Cancer in the Netherlands.
Topics: Aged; Aged, 80 and over; Analgesics; Antineoplastic Agents; Dipeptides; Fatigue; Follow-Up Studies; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Middle Aged; Netherlands; Pain; Pain Measurement; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Treatment Outcome; Xerostomia | 2019 |
Development of a [177Lu]BPAMD labeling kit and an automated synthesis module for routine bone targeted endoradiotherapy.
Topics: Aged; Amides; Bone and Bones; Bone Neoplasms; Diphosphonates; Humans; Lutetium; Male; Pain; Radioisotopes; Radiopharmaceuticals; Reagent Kits, Diagnostic; Staining and Labeling | 2015 |
177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy.
Topics: Aged; Antigens, Surface; Cohort Studies; Dipeptides; Disease-Free Survival; Edetic Acid; Erythrocyte Count; Gallium Isotopes; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Heterocyclic Compounds, 1-Ring; Humans; Leukocyte Count; Lutetium; Male; Neoplasm Metastasis; Oligopeptides; Organometallic Compounds; Pain; Patient Selection; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiometry; Radiopharmaceuticals; Treatment Outcome | 2016 |
Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
Topics: Animals; Bone and Bones; Diphosphonates; Feasibility Studies; Hydrogen-Ion Concentration; Lutetium; Male; Pain; Pain Management; Palliative Care; Quality Control; Radiochemistry; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Temperature; Time Factors | 2011 |
177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation.
Topics: Animals; Bone Neoplasms; Heterocyclic Compounds, 1-Ring; Lutetium; Organophosphonates; Organophosphorus Compounds; Pain; Palliative Care; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution | 2002 |
Comparative studies of 177Lu-EDTMP and 177Lu-DOTMP as potential agents for palliative radiotherapy of bone metastasis.
Topics: Animals; Bone Neoplasms; Drug Stability; Lutetium; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Rabbits; Radioisotopes; Rats; Rats, Wistar; Tissue Distribution | 2008 |
177Lu-EDTMP: a potential therapeutic bone agent.
Topics: Animals; Beta Particles; Bone and Bones; Bone Neoplasms; Femur; Gamma Rays; Humans; Lutetium; Male; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Radiopharmaceuticals; Rats; Rats, Wistar; Technetium Tc 99m Medronate; Time Factors; Tissue Distribution | 1998 |